Avacta : Results for the Year Ended 31 December 2023
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS NO. 596/2014 AS IT FORMS...
Stay updated with breaking news from Coris Bioconcept. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS NO. 596/2014 AS IT FORMS...
Avacta appoints new Chief Executive Officer Christina Coughlin, MD PhD Clinical proof-of-concept demonstrated for Avacta's lead programme AVA6000 and proof-of-mechanism for the...
/PRNewswire/ -- The "Respiratory Syncytial Virus Diagnostics Market Size, Share & Trends Analysis Report By Product (DFA, RADT, Molecular Diagnostics,...
Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The
Chairman predicts "huge potential value" both for cancer patients and investors in the next period.